一名32岁患者在使用达比加群直接口服抗凝治疗期间出现巨大移动性左心室血栓形成
Large Mobile Left Ventricular Thrombi Formation in a 32-Year-Old Despite Direct Oral Anticoagulation With Dabigatran.
作者信息
Weberling Lukas Damian, Steen Henning, Frey Norbert, André Florian
机构信息
Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Heidelberg, Germany.
German Centre for Cardiovascular Research, Partner Site Heidelberg, Heidelberg, Germany.
出版信息
JACC Case Rep. 2022 Aug 17;4(16):1015-1019. doi: 10.1016/j.jaccas.2022.05.033.
Direct oral anticoagulant agents (DOACs) are widely used in the treatment of arterial and venous thrombi. We report the case of a 32-year-old patient who was receiving permanent DOAC therapy. Despite adequate use, 2 large left ventricular thrombi developed. Surgical thrombectomy was performed. The patient recovered well and received anticoagulation with phenprocoumon thereafter. ( ).
直接口服抗凝剂（DOACs）广泛用于治疗动脉和静脉血栓。我们报告了一例32岁正在接受DOACs长期治疗的患者。尽管用药充分，但仍形成了2个大的左心室血栓。患者接受了手术取栓治疗。患者恢复良好，此后接受苯丙香豆素抗凝治疗。（ ）
Zotero 插件